FDA Approved: DOXERCALCIFEROL — Original Application (Meitheal Pharmaceuticals Inc.)

View source ↗

Summary

FDA approves the original ANDA for doxercalciferol, a generic vitamin D analog from Meitheal Pharmaceuticals, for the treatment of secondary hyperparathyroidism…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperparathyroidism

Drugs mentioned

• DOXERCALCIFEROL (Doxercalciferol)

Snippet

ORIG AP for DOXERCALCIFEROL (DOXERCALCIFEROL)